Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hepatocellular carcinoma that develops following exposure to aflatoxin.
Biomarker and diagnostic research for aflatoxin-related hepatocellular carcinoma has been reported in the published literature.
No clinical trials have been registered for aflatoxin-related hepatocellular carcinoma.
193 publications have been identified in PubMed for aflatoxin-related hepatocellular carcinoma. Research spans Basic Science / Preclinical (40%), Review / Meta-Analysis (38%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 78 | 40% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:50 AM UTC
Research summaries
74 |
38% |
Disease patterns and progression | 14 | 7% |
New treatment approaches | 10 | 5% |
Other research | 6 | 3% |
Clinical study results | 6 | 3% |
Testing and diagnosis research | 5 | 3% |
Ceccarelli G (2026). [PMID: 40828366](https://pubmed.ncbi.nlm.nih.gov/40828366/). *Journal of immigrant and minority health*. [Epidemiology / Natural History]
Torbenson M (2026). [PMID: 41804058](https://pubmed.ncbi.nlm.nih.gov/41804058/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Machado MV (2026). [PMID: 41590352](https://pubmed.ncbi.nlm.nih.gov/41590352/). *Current oncology (Toronto, Ont.)*. [Epidemiology / Natural History]
Sadik JA (2026). [PMID: 41101517](https://pubmed.ncbi.nlm.nih.gov/41101517/). *Regulatory toxicology and pharmacology : RTP*. [Epidemiology / Natural History]
Lv G (2026). [PMID: 40796068](https://pubmed.ncbi.nlm.nih.gov/40796068/). *Cancer letters*. [Basic Science / Preclinical]
Kang B (2026). [PMID: 42071890](https://pubmed.ncbi.nlm.nih.gov/42071890/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Song Q (2026). [PMID: 42108298](https://pubmed.ncbi.nlm.nih.gov/42108298/). *Methods Mol Biol*. [Review / Meta-Analysis]
Wang H (2026). [PMID: 40850678](https://pubmed.ncbi.nlm.nih.gov/40850678/). *J Adv Res*. [Review / Meta-Analysis]
Anton A (2026). [PMID: 41468910](https://pubmed.ncbi.nlm.nih.gov/41468910/). *Semin Liver Dis*. [Review / Meta-Analysis]
Hsiehchen D (2026). [PMID: 41831431](https://pubmed.ncbi.nlm.nih.gov/41831431/). *Med*. [Review / Meta-Analysis]